New Key Statistics Module, Z-Score and F-Score
NYSE:RCUS Key Ratios
Market Cap $ M | 1,596.22 |
Enterprise Value $ M | 572.21 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 2.20 |
Price/Sales | 5.86 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 237.00 |
EPS (TTM) $ | -3.11 |
Beneish M-Score | -2.01 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -2.54 |
EV-to-EBITDA | -2.65 |
PEG | -- |
Shares Outstanding M | 90.95 |
Net Margin (%) | -97.47 |
Operating Margin % | -105.49 |
Pre-tax Margin (%) | -95.78 |
Quick Ratio | 5.22 |
Current Ratio | 5.22 |
ROA % (ttm) | -19.08 |
ROE % (ttm) | -40.46 |
ROIC % (ttm) | -68.94 |
Dividend Yield % | -- |
Altman Z-Score | 1.08 |
RCUS Number of Guru Trades
RCUS Volume of Guru Trades
Gurus Latest Trades with NYSE:RCUS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NYSE:RCUS is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Arcus Biosciences Inc Insider Transactions
No Available Data
News about NYSE:RCUS
Total 0- 1